(Q50109689)
Statements
1 reference
Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use. (English)
1 reference
Michael V Knopp
1 reference
Thomas Balzer
1 reference
Marc Esser
1 reference
Franciska K Kashanian
1 reference
Predip Paul
1 reference
Hans P Niendorf
1 reference
1 June 2006
1 reference
1 reference
41
1 reference
6
1 reference
491-499
1 reference
Identifiers
1 reference